China gives India competition in bulk drugs market

09/10/2013 | Business Standard (India)

China's exports of bulk drugs to India are growing at the rate of 30% annually, while Indian exporters are finding it difficult to enter the Chinese market, according to Indian pharmaceutical experts. Bulk drugs from China are growing in popularity because of price and availability, said Sunil Parekh of the global research company Crisil. Cheaper API imports from China are hurting domestic Indian API makers but may be a boon to generic drug companies.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD